The authors present TrialGPT 2.0, an AI-assisted clinical trial recommendation system designed for real-world deployment that assesses which trials warrant consideration based on patient needs and workflow priorities.

  • In retrospective multicenter cohorts of 288 cases, the system retrieved at least one clinician-recommended trial in its top 10 recommendations for approximately 91% of cases.
  • The system reduced clinician screening time by 55.0% in the retrospective evaluation.
  • In a six-month prospective evaluation within an active precision oncology tumor board, TrialGPT 2.0 expanded patient access to clinical trial participation by 90.9%.
  • The authors introduce NIH-TrialBench, a clinician-authored dataset comprising 126 diverse synthetic patient vignettes and matching scenarios from 11 NIH Institutes and Centers.

These results support the value of AI in assisting clinical trial matching by improving clinician efficiency and identifying frequently overlooked trial opportunities to accelerate accrual.